SEC Filing Summary: Neuralstem, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuralstem, Inc. on March 15, 2007. The filing discloses the completion of a private placement of equity securities to institutional investors. Note: The request metadata references "Palisade Bio, Inc.", but the filing text explicitly identifies the registrant as "Neuralstem, Inc."
Key Financial Metrics
- Gross Proceeds: $5,135,000.00
- Transaction Fees and Expenses: $431,000.00
- Units Issued: 2,054,000 units (priced at $2.50 per unit)
- Common Shares Issued: 2,054,000 shares
- Warrants Issued to Investors: Warrants to purchase 1,027,000 shares (exercise price $3.00)
- Placement Agent Warrant: Warrant to purchase 246,480 shares (exercise price $3.00)
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transaction-specific report rather than a periodic financial statement.
Material Changes
The primary material change is the increase in the company's capital base through the issuance of 2,054,000 shares of common stock and associated warrants. This transaction resulted in immediate gross proceeds of $5.135 million, net of $431,000 in fees and expenses.
Outlook, Risks, and Contingencies
The filing does not contain management commentary on future guidance, operational outlook, or specific risk factors beyond the standard disclosure of the transaction terms. Investors received registration rights regarding the underlying securities. The filing includes attached exhibits for the Securities Purchase Agreement, Common Stock Purchase Warrant, and Registration Rights Agreement.
Key Facts for Investor Verification
- Verify the net proceeds calculation after deducting the $431,000 in fees from the $5,135,000 gross proceeds.
- Confirm the total potential dilution from the 1,027,000 investor warrants and the 246,480 placement agent warrant.
- Review the attached Registration Rights Agreement to understand the timeline for public trading of these securities.
- Check the company's updated capitalization table to reflect the new share count and warrant obligations.